Enhanced Oral Bioavailability of MT-102, a New Anti-inflammatory Agent, via a Ternary Solid Dispersion Formulation

This study aimed to develop a solid dispersion (SD) of MT-102, a new anti-inflammatory agent, to improve its oral bioavailability. The ternary SD formulations of MT-102 (a poorly soluble extract of Isatis indigotica and Juglans mandshurica) were prepared using a solvent evaporation method with vario...

Descripción completa

Detalles Bibliográficos
Autores principales: Bajracharya, Rajiv, Song, Jae Geun, Lee, Sang Hoon, Jeong, Seong Hoon, Han, Hyo-Kyung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9323944/
https://www.ncbi.nlm.nih.gov/pubmed/35890405
http://dx.doi.org/10.3390/pharmaceutics14071510

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9323944/
https://www.ncbi.nlm.nih.gov/pubmed/35890405
http://dx.doi.org/10.3390/pharmaceutics14071510

Ejemplares similares